COMBINATIONS OF TRPV4 ANTAGONISTS
    4.
    发明公开
    COMBINATIONS OF TRPV4 ANTAGONISTS 审中-公开
    TRPV4-ANTAGONISTEN KOMBINATIONEN

    公开(公告)号:EP3121177A1

    公开(公告)日:2017-01-25

    申请号:EP16162808.6

    申请日:2012-06-15

    摘要: A combination comprising a compound of Formula (I):

    or a pharmaceutically acceptable salt thereof;
    and one or more other therapeutic agents, selected from the group consisting of endothelin receptor antagonists, angiotensin converting enzyme (ACE) inhibitors, angiotension II receptor antagonists, vasopeptidase inhibitors, vasopressin receptor modulators, diuretics, digoxin, beta blocker, aldosterone antagonists, iontropes, NSAIDS, nitric oxide donors, calcium channel modulators, muscarinic antagonists, steroidal anti-inflammatory drugs, bronchodilators, anti-histamines, leukotriene antagonist, HMG-CoA reductase inhibitors, dual non-selective β-adrenoceptor and α 1 -adrenoceptor antagonists, type-5 phosphodiesterase inhibitors, and renin inhibitors.

    摘要翻译: 包含式(I)化合物或其药学上可接受的盐的组合: 和一种或多种选自内皮素受体拮抗剂,血管紧张素转换酶(ACE)抑制剂,血管紧张素II受体拮抗剂,血管肽酶抑制剂,加压素受体调节剂,利尿剂,地高辛,β阻断剂,醛固酮拮抗剂,离子转运体, NSAIDS,一氧化氮供体,钙通道调节剂,毒蕈碱拮抗剂,甾体抗炎药,支气管扩张剂,抗组胺药,白三烯拮抗剂,HMG-CoA还原酶抑制剂,双重非选择性肾上腺素受体和±1-肾上腺素能受体拮抗剂, 5磷酸二酯酶抑制剂和肾素抑制剂。